Clinical Trial

GU-01: Glycyrrhizin in Prostate Cancer

Study acronym: GU-01
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a pilot, randomized, window-of-opportunity treatment trial in which participants with previously untreated prostate cancer (PCa) who are candidates for surgery (radical prostatectomy)
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2024-04-18; most recent amendment 2026-02-19.
Status change: Not Yet Recruiting → Recruiting 2024-04-25
Trial Details
NCT Number NCT06378346
Lead Sponsor University of Illinois at Chicago
Conditions Prostate Cancer
Enrollment 60 participants
Start Date 2024-07-25
Primary Completion 2027-03 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2026-02-23